2.7.1.7 Adenosine triphosphate citrate lyase (ACL) inhibitors
Expand All / Expand All (incl. cost)
Documents
-
Primary Care
-
Secondary Care
-
Primary and Secondary Care
IMPLEMENTATION GUIDANCE FOR NICE TA 694 - Bempedoic acid
Uploaded By:
Renewal: 09/2022
Approved: 09/2021
Last Reviewed: 10/2021
Caution: This document is due for renewal and may be out of date
Document linked to:
| Drug | Section |
|---|---|
| Bempedoic acid |
2.7.1.7 Adenosine triphosphate citrate lyase (ACL) inhibitors
|
Please see implementation guidance for further information: https://www.eastkentformulary.nhs.uk/media/1642/implementation-guidance-for-nice-ta-694-bempedoic-acid.pdf
Please see NICE TA: https://www.nice.org.uk/guidance/ta694/chapter/1-Recommendations
| Pack | Price |
|---|---|
| 28 tablet | £55.44 |
NICE recommends Bempedoic Acid may be used only in combination with ezetimibe
| Pack | Price |
|---|---|
| 28 tablet | £55.44 |